Cody Shandraw

cody-shandraw

Cody Shandraw is a visionary entrepreneur and seasoned investor with a prolific track record of identifying and nurturing ventures in emerging industries. At the helm of Phyto Partners, a venture capital fund dedicated to the burgeoning Cannabis industry, Cody has demonstrated an exceptional ability to foresee market trends and back businesses poised for significant growth. His expertise doesn’t stop there; as the founder of Ambria Capital, he leverages a comprehensive analytical approach to invest in emerging public and private companies across the agriculture, consumer, healthcare, and technology sectors. Since 2019, Ambria Capital has connected industry leaders with market opportunities, thanks to Cody’s unparalleled network of contacts and deep market insights.

In addition to his venture capital endeavors, Cody has made a profound impact on the healthcare sector through Healing Realty Trust, Inc. This data-driven company invests in and owns healthcare-related real estate assets, playing a pivotal role in the development and operation of facilities that meet the growing demand for healthcare services. From Psychedelic Assisted Therapy Centers to sports medicine clinics, Cody’s investments support innovative care delivery models that address critical health needs.

Cody’s journey as a serial entrepreneur began in Western New York, where his early ventures laid the foundation for his future successes. Now residing in Southern Florida with his family, Cody continues to manage market assessment projects, due diligence, and build client and partner relationships. His passion for advocating the healing powers of new medicines, particularly in treating mental health disorders and addictions, guides his investment choices. Featured on several podcasts and conferences, Cody Shandraw stands as a testament to the power of strategic investment in transforming industries and improving lives.

Maria Velkova

maria-velkova

Maria Velkova is a Managing Partner at Tabula Rasa Ventures (TRV), a pioneering investment firm building the future of human health – defined as holistic, personalized, preventative, and democratized, underpinned by rigorous scientific and clinical evidence.

Maria is a seasoned biopharma executive with 10+ years of experience developing and implementing global drug strategy for top pharma companies like Roche, AstraZeneca, Novartis, and more. Her expertise bridges the silos in drug development and spans across R&D, clinical trial design, product launch, regulatory affairs, business intelligence, sales, operations and M&A.
Maria is recognized as one of the top 15 Global Psychedelics Executives, has led high profile events at Davos, alongside the World Economic Forum, and pioneered education on psychedelic therapeutics in the Arab Region.
Maria holds a degree in BSc Pharmacology from Leeds University and MPhil in Bioscience Enterprise from Cambridge University, where she was a visiting lecturer in 2016.

 

Maria is passionate about shaping the future landscape of healthcare and helping companies steer successfully in bringing true health innovations to all patients.

Garri Zmudze

garri-zmudze

Join us as we delve into the intersection of biotech and longevity with Garri Zmudze, who brings unparalleled expertise to the table. In this episode, we’ll explore how Garri, as the General Partner of LongeVC and advisor to PsyMed Ventures, integrates cutting-edge health technologies with holistic aging and well-being solutions. Discover the latest trends in biotech and longevity, gain insights from Garri’s notable exits in ventures like Insilico Medicine and Deep Longevity, and learn about his advisory roles with prominent web3 and biotech firms, including Cointelegraph, IoTEX, and Longenesis. Don’t miss this insightful conversation on the Business of HLTH Podcast!